SAM Pharmaceutical Celebrates 55 Years with Commissioning of Advanced Manufacturing Plant
SAM Pharmaceutical Limited, a prominent Nigerian pharmaceutical manufacturer with over five decades of experience in human and veterinary medicine, has marked its 55th anniversary with the inauguration of a state-of-the-art manufacturing facility in Ota, Ogun State. This significant event took place on Wednesday, April 8, 2026, drawing a wide array of key stakeholders from the healthcare sector.
High-Profile Attendance and Goodwill Messages
The commissioning ceremony was attended by numerous dignitaries who delivered goodwill messages, highlighting the importance of this development for Nigeria's pharmaceutical industry. Notable guests included the Deputy Governor of Ogun State, Engr. Noimot Salako-Oyedele, and the Honourable Minister of State for Health and Social Welfare, Dr. Iziaq Adekunle Salako. Also present were Prof. Mojisola Christianah Adeyeye, Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), and Hon. Tunji Akinosi, representing the Ado-Odo/Ota Federal Constituency.
Other distinguished attendees included Dr. Marcellina Oluwatomi Coker, Ogun State Commissioner for Health, Dr. Oluwaserimi Adewumi Ajetunmobi, Oyo State Commissioner for Health, and HRH Oba Professor Abdulkabir Adeyemi Obalanlege (Lanlege Ekun II), the Olota of Ota. The event also featured Dr. Abdu Mukhtar, National Coordinator of the Presidential Initiative For Unlocking the Healthcare Value Chain, Otunba Adeniyi Adebayo, Former Minister of Industry and Trade, and Mr. C. Kannan, the Consul General of India.
Key figures from the pharmaceutical sector were also in attendance, such as Pharm. Ibrahim Babashehu Ahmed, Registrar of the Pharmacists Council of Nigeria (PCN), and Pharm. Ayuba Tanko Ibrahim, President of the Pharmaceutical Society of Nigeria (PSN). The gathering included traditional rulers, policymakers, and private sector leaders, underscoring the broad support for SAM Pharmaceutical's initiative.
Facility Specifications and Production Capacity
The newly commissioned facility is designed to meet World Health Organization current Good Manufacturing Practice (cGMP) standards and aligns with international regulatory benchmarks. This plant significantly boosts SAM Pharmaceutical's production capabilities, enabling the manufacture of over 400 million tablets, 50 million capsules, 2 million bottles of liquid formulations, and 1 million sachet-based products monthly. Expansion lines are already under development to further increase output and address growing market demands.
Strategic Milestone and Corporate Vision
During the event, Mr. Amit Bhojwani, Chairman and Managing Director of SAM Pharmaceutical, described the facility as a strategic milestone in the company's evolution. He emphasized its role in strengthening local pharmaceutical production, reducing dependence on imports, and enhancing national health security. As a pioneer in veterinary product manufacturing in Nigeria, SAM Pharmaceutical continues to play a critical role in advancing healthcare outcomes through innovation and quality manufacturing.
Celebratory Reception and Entertainment
The commissioning concluded with a celebratory cocktail reception at the Lagos Continental Hotel, where stakeholders gathered for networking and entertainment. Guests enjoyed live performances, including a headline appearance by Afrobeats artist Ladipoe, along with cultural showcases and interactive performances. This festive atmosphere provided a fitting end to a day dedicated to celebrating corporate achievement and the company's longstanding contributions to the pharmaceutical industry.
About SAM Pharmaceutical Limited
SAM Pharmaceutical Limited is a leading indigenous pharmaceutical company in Nigeria, specializing in the manufacturing and distribution of high-quality human and veterinary medicinal products. With over 55 years of industry experience, the company remains committed to advancing healthcare through strict adherence to regulatory standards and continuous innovation.
